Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3403105rdf:typepubmed:Citationlld:pubmed
pubmed-article:3403105lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:3403105lifeskim:mentionsumls-concept:C0001792lld:lifeskim
pubmed-article:3403105lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:3403105lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:3403105lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:3403105lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:3403105lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:3403105lifeskim:mentionsumls-concept:C0031990lld:lifeskim
pubmed-article:3403105lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:3403105lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:3403105lifeskim:mentionsumls-concept:C0053407lld:lifeskim
pubmed-article:3403105pubmed:issue3lld:pubmed
pubmed-article:3403105pubmed:dateCreated1988-9-15lld:pubmed
pubmed-article:3403105pubmed:abstractTextThe age effect on the kinetics of piroxicam at the steady-state after oral administration of piroxicam beta-cyclodextrin was evaluated. The mean plasma concentration of piroxicam at the steady-state was significantly higher in elderly subjects (9.30 +/- 0.69 micrograms/ml mean +/- s.e.) than in younger adults (6.24 +/- 0.58 micrograms/ml mean +/- s.e.). Even though the distribution volume tended to be lower in elderly subjects (106.37 ml/kg), it did not show substantial differences in the two groups whereas the correlation between clearance and age was significant (p less than 0.05). It is therefore confirmed that piroxicam beta-cyclodextrin has the same pharmacokinetic behaviour at the steady-state in elderly subjects, as the active principle in a non-complexed form.lld:pubmed
pubmed-article:3403105pubmed:languageenglld:pubmed
pubmed-article:3403105pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3403105pubmed:citationSubsetIMlld:pubmed
pubmed-article:3403105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3403105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3403105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3403105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3403105pubmed:statusMEDLINElld:pubmed
pubmed-article:3403105pubmed:issn0251-1649lld:pubmed
pubmed-article:3403105pubmed:authorpubmed-author:D'AmbrosioEElld:pubmed
pubmed-article:3403105pubmed:authorpubmed-author:BoscariniMMlld:pubmed
pubmed-article:3403105pubmed:authorpubmed-author:ScaliGGlld:pubmed
pubmed-article:3403105pubmed:authorpubmed-author:CesariFFlld:pubmed
pubmed-article:3403105pubmed:authorpubmed-author:BonatiCClld:pubmed
pubmed-article:3403105pubmed:authorpubmed-author:BufalinoLLlld:pubmed
pubmed-article:3403105pubmed:authorpubmed-author:AcerbiDDlld:pubmed
pubmed-article:3403105pubmed:authorpubmed-author:MansantiPPlld:pubmed
pubmed-article:3403105pubmed:issnTypePrintlld:pubmed
pubmed-article:3403105pubmed:volume8lld:pubmed
pubmed-article:3403105pubmed:ownerNLMlld:pubmed
pubmed-article:3403105pubmed:authorsCompleteYlld:pubmed
pubmed-article:3403105pubmed:pagination175-80lld:pubmed
pubmed-article:3403105pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3403105pubmed:meshHeadingpubmed-meshheading:3403105-...lld:pubmed
pubmed-article:3403105pubmed:meshHeadingpubmed-meshheading:3403105-...lld:pubmed
pubmed-article:3403105pubmed:meshHeadingpubmed-meshheading:3403105-...lld:pubmed
pubmed-article:3403105pubmed:meshHeadingpubmed-meshheading:3403105-...lld:pubmed
pubmed-article:3403105pubmed:meshHeadingpubmed-meshheading:3403105-...lld:pubmed
pubmed-article:3403105pubmed:meshHeadingpubmed-meshheading:3403105-...lld:pubmed
pubmed-article:3403105pubmed:meshHeadingpubmed-meshheading:3403105-...lld:pubmed
pubmed-article:3403105pubmed:meshHeadingpubmed-meshheading:3403105-...lld:pubmed
pubmed-article:3403105pubmed:meshHeadingpubmed-meshheading:3403105-...lld:pubmed
pubmed-article:3403105pubmed:meshHeadingpubmed-meshheading:3403105-...lld:pubmed
pubmed-article:3403105pubmed:meshHeadingpubmed-meshheading:3403105-...lld:pubmed
pubmed-article:3403105pubmed:year1988lld:pubmed
pubmed-article:3403105pubmed:articleTitlePharmacokinetic study on piroxicam at the steady-state in elderly subjects and younger adults after administration of piroxicam beta-cyclodextrin.lld:pubmed
pubmed-article:3403105pubmed:affiliationPharmacotoxicological Research Laboratories, Chiesi Farmaceutici S.p.A., Parma, Italy.lld:pubmed
pubmed-article:3403105pubmed:publicationTypeJournal Articlelld:pubmed